130 related articles for article (PubMed ID: 11698066)
1. Dexamethasone modulates hypotension induced by opioids in anaesthetised rats.
Sorrentino R; Capasso A; d'Emmanuele di Villa Bianca R; Pinto A
Eur J Pharmacol; 2001 Oct; 430(1):79-85. PubMed ID: 11698066
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L
J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345
[TBL] [Abstract][Full Text] [Related]
3. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone-induced selective inhibition of the central mu opioid receptor: functional in vivo and in vitro evidence in rodents.
Pieretti S; Di Giannuario A; Domenici MR; Sagratella S; Capasso A; Sorrentino L; Loizzo A
Br J Pharmacol; 1994 Dec; 113(4):1416-22. PubMed ID: 7889299
[TBL] [Abstract][Full Text] [Related]
6. Baroreflex-mediated bradycardia is blunted by intravenous mu- but not kappa-opioid agonists.
Omoniyi AT; Wu D; Soong Y; Szeto HH
J Cardiovasc Pharmacol; 1998 Jun; 31(6):954-9. PubMed ID: 9641482
[TBL] [Abstract][Full Text] [Related]
7. Further studies on the involvement of the arachidonic acid cascade in the acute dependence produced by mu, kappa and delta opioid agonists in isolated tissues.
Capasso A
Neuropharmacology; 1999 Jun; 38(6):871-7. PubMed ID: 10465690
[TBL] [Abstract][Full Text] [Related]
8. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
9. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
10. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
11. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
Randich A; Robertson JD; Willingham T
Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
[TBL] [Abstract][Full Text] [Related]
12. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
14. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
[TBL] [Abstract][Full Text] [Related]
15. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
16. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
17. U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites.
Sheldon RJ; Nunan L; Porreca F
Eur J Pharmacol; 1988 Feb; 146(2-3):229-35. PubMed ID: 2836207
[TBL] [Abstract][Full Text] [Related]
18. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
19. Differential antagonism of mu agonists by U50,488H in the rat.
Porreca F; Tortella FC
Life Sci; 1987 Dec; 41(23):2511-6. PubMed ID: 2824958
[TBL] [Abstract][Full Text] [Related]
20. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]